The Food and Drug Administration (FDA) is announcing a public Workshop entitled “Clinical Considerations of Risk in the Postmarket Environment.”
The purpose of the workshop is to provide a forum for an interactive discussion on assessing changes in medical device risk as quality and safety situations arise in the postmarket setting when a patient, operator, or member of the public actually uses the device.
- Date, Time and Location
- Federal Register Notice
- Webcast
- Agenda
- Registration
- Contact Us
FDA Campus Information
[email protected].
[email protected].
[email protected].